格隆汇9月9日丨健康160(02656.HK)发布公告，公司拟全球发售3364.55万股股份，中国香港发售股份336.475万股，国际发售股份3028.075万股，另有约15%的超额配股权；2025年9月9日至9月12日招股，预期定价日为9月15日；发售价将为每股发售股份11.89-14.86港元，每手买卖单位为250股，申万宏源香港及清科资本为联席保荐人；预期股份将于2025年9月17日开始在联交所买卖。
责任编辑：栎树
格隆汇9月9日丨健康160(02656.HK)发布公告，公司拟全球发售3364.55万股股份，中国香港发售股份336.475万股，国际发售股份3028.075万股，另有约15%的超额配股权；2025年9月9日至9月12日招股，预期定价日为9月15日；发售价将为每股发售股份11.89-14.86港元，每手买卖单位为250股，申万宏源香港及清科资本为联席保荐人；预期股份将于2025年9月17日开始在联交所买卖。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.